248 related articles for article (PubMed ID: 1713611)
41. The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta.
Cagliero E; Roth T; Taylor AW; Lorenzi M
Lab Invest; 1995 Nov; 73(5):667-73. PubMed ID: 7474940
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
Petit-Koskas E; Génot E; Lawrence D; Kolb JP
Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
[TBL] [Abstract][Full Text] [Related]
43. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
44. Characterization of transforming growth factor-beta growth regulatory effects and receptors on bovine mammary cells.
Woodward TL; Dumont N; O'Connor-McCourt M; Turner JD; Philip A
J Cell Physiol; 1995 Nov; 165(2):339-48. PubMed ID: 7593212
[TBL] [Abstract][Full Text] [Related]
45. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
47. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
49. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.
Mitchell EJ; Fitz-Gibbon L; O'Connor-McCourt MD
J Cell Physiol; 1992 Feb; 150(2):334-43. PubMed ID: 1310325
[TBL] [Abstract][Full Text] [Related]
50. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
51. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
Batova A; Danielpour D; Pirisi L; Creek KE
Cell Growth Differ; 1992 Nov; 3(11):763-72. PubMed ID: 1334692
[TBL] [Abstract][Full Text] [Related]
52. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
Whitson RH; Wong WL; Itakura K
J Cell Biochem; 1991 Sep; 47(1):31-42. PubMed ID: 1658013
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.
Blomhoff HK; Smeland E; Mustafa AS; Godal T; Ohlsson R
Eur J Immunol; 1987 Feb; 17(2):299-301. PubMed ID: 3030769
[TBL] [Abstract][Full Text] [Related]
54. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression.
Weller M; Constam DB; Malipiero U; Fontana A
Eur J Immunol; 1994 Jun; 24(6):1293-300. PubMed ID: 8206089
[TBL] [Abstract][Full Text] [Related]
56. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.
Brandes ME; Mai UE; Ohura K; Wahl SM
J Immunol; 1991 Sep; 147(5):1600-6. PubMed ID: 1652608
[TBL] [Abstract][Full Text] [Related]
57. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
Serrero G; Zhou J; Mills D; LePak N
J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
Stromberg K; Collins TJ; Gordon AW; Jackson CL; Johnson GR
Cancer Res; 1992 Jan; 52(2):341-7. PubMed ID: 1309440
[TBL] [Abstract][Full Text] [Related]
59. IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes.
Wong HL; Welch GR; Brandes ME; Wahl SM
J Immunol; 1991 Sep; 147(6):1843-8. PubMed ID: 1653804
[TBL] [Abstract][Full Text] [Related]
60. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
Inman GJ; Allday MJ
J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
